Cancer statistics, 2016

Cited by (1,069)

Items 901–1,000 of 1,069

1. Deep Learning Role in Early Diagnosis of Prostate Cancer
   Reda, Islam, Khalil, Ashraf, Elmogy, Mohammed, Abou El-Fetouh, Ahmed, Shalaby, Ahmed, Abou El-Ghar, Mohamed, Elmaghraby, Adel, Ghazal, Mohammed, El-Baz, Ayman · 2018 · Technology in Cancer Research & Treatment
2. Esophageal Cancer Metastases to Unexpected Sites: A Systematic Review
   Osama Shaheen, Abdulaziz Ghibour, Bayan Alsaid · 2017 · Gastroenterology Research and Practice
3. Hsa_circ_0001649: A circular RNA and potential novel biomarker for colorectal cancer
   Wenxin Ji, Chunli Qiu, Mao Wang, Ning Mao, Shaofeng Wu, Yinhai Dai · 2018 · Biochemical and Biophysical Research Communications
4. Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer
   Tulasigeri M. Totiger, Supriya Srinivasan, Venkatakrishna Rao Jala, Purushottam Lamichhane, Austin R. Dosch, Alexander A. Gaidarski, Chandrashekhar G. Joshi, Shobith Rangappa, Jason A. Castellanos, Praveen Kumar Vemula et al. · 2018 · Molecular Cancer Therapeutics
5. The experience of cancer‐related fatigue, exercise and exercise adherence among women breast cancer survivors: Insights from focus group interviews
   Sue Kim, Jeehee Han, Min Young Lee, Min Kyeong Jang · 2019 · Journal of Clinical Nursing
6. Noninvasive Cancer Diagnosis In Vivo Based on a Viscosity-Activated Near-Infrared Fluorescent Probe
   Junling Yin, Xiuqi Kong, Weiying Lin · 2021 · Analytical Chemistry
7. Pharmacological and Therapeutic Properties of Punica granatum Phytochemicals: Possible Roles in Breast Cancer
   Marius Moga, Oana Gabriela Dimienescu, Andreea Bălan, Lorena Dima, Sebastian Ionut Toma, Nicușor Florin Bîgiu, Alexandru Blidaru · 2021 · Molecules
8. Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings
   Christine M. Bestvina, Gini F. Fleming · 2016 · The Oncologist
9. Protective Role of Dietary Berries in Cancer
   Aleksandra S. Kristo, Dorothy J. Klimis‐Zacas, Angelos K. Sikalidis · 2016 · Antioxidants
10. Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma
    Brian I. Rini, David F. McDermott, Hans J. Hammers, William Bro, Ronald M. Bukowski, Bernard Faba, Jo Faba, Robert A. Figlin, Thomas E. Hutson, Eric W. Jonasch et al. · 2016 · Journal for ImmunoTherapy of Cancer
11. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer
    Xiao Wang, Zhen Chang Liang, Xin Xu, Jiangfeng Li, Yi Zhu, Shuai Meng, Shiqi Li, Song Wang, Bo Xie, Alin Ji et al. · 2016 · Cell Death and Disease
12. Allosteric MEK1/2 inhibitors including cobimetanib and trametinib in the treatment of cutaneous melanomas.
    R. Roskoski · 2017 · Pharmacological Research
13. Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis
    Aerken Maolake, Kouji Izumi, Kazuyoshi Shigehara, Ariunbold Natsagdorj, Hiroaki Iwamoto, Suguru Kadomoto, Yuta Takezawa, Kazuaki Machioka, Kazutaka Narimoto, Mikio Namiki et al. · 2016 · Oncotarget
14. A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review
    Evan L. Fogel, Safi Shahda, Kumaresan Sandrasegaran, John M. DeWitt, Jeffrey J. Easler, David M. Agarwal, Mackenzie A. Eagleson, Nicholas Joseph Zyromski, Michael Garrett House, Susannah G. Ellsworth et al. · 2017 · The American Journal of Gastroenterology
15. Frequency of Incidental Findings and Subsequent Evaluation in Low-Dose Computed Tomographic Scans for Lung Cancer Screening
    Lillie Morgan, Humberto Choi, Michal Reid, Ali I. Khawaja, Peter J. Mazzone · 2017 · Annals of the American Thoracic Society
16. Enzyme targeting strategies for prevention and treatment of cancer: Implications for cancer therapy
    Mohammad Hassan Baig, Mohd Adil, Rosina Khan, Surendar Reddy Dhadi, Khurshid Ahmad, Gulam Rabbani, Tufail Bashir, Mohammad Azhar Imran, Fohad Mabood Husain, Eun Ju Lee et al. · 2017 · Seminars in Cancer Biology
17. CircRNA_100782 regulates pancreatic carcinoma proliferation through the IL6-STAT3 pathway
    Genwen Chen, Yanting Shi, Yu Zhang, Jianyong Sun · 2017 · OncoTargets and Therapy
18. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling
    Yingya Cao, Jing Yu, Tingting Liu, Kai-Xia Yang, Li-Yan Yang, Qun Chen, Feng Shi, Jia‐Jie Hao, Yan Cai, Ming‐Rong Wang et al. · 2018 · Cell Death and Disease
19. LOX-1 and cancer: an indissoluble liaison
    Michela Murdocca, Claudia De Masi, Sabina Pucci, Ruggiero Mango, Giuseppe Novelli, C. Di Natale, Federica Carla Sangiuolo · 2021 · Cancer Gene Therapy
20. Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies
    Loredana Puca, Panagiotis J. Vlachostergios, Himisha Beltran · 2018 · Cold Spring Harbor Perspectives in Medicine
21. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4
    Dantong Cheng, Senlin Zhao, Huamei Tang, Dongyuan Zhang, Hongcheng Sun, Fudong Yu, Weiliang Jiang, Ben Yue, Jingtao Wang, Meng Zhang et al. · 2016 · Oncotarget · Retracted
22. Nanoparticles for imaging and treatment of metastatic breast cancer
    Qing-Xin Mu, Hui Wang, Mi-Qin Zhang · 2016 · Expert Opinion on Drug Delivery
23. Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice
    Apurva Jain, Lawrence N. Kwong, Milind M. Javle · 2016 · Current Treatment Options in Oncology
24. Targeted hydroxyethyl starch prodrug for inhibiting the growth and metastasis of prostate cancer
    Kaidong Zhao, Di Li, Weiguo Xu, Jianxun Ding, Weiqian Jiang, Mingqiang Li, Chunxi Wang, Xuesi Chen · 2016 · Biomaterials
25. SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer
    Australian Pancreatic Cancer Genome Initiative, Nathanial Lachlan Ewart Harris, Claire Vennin, James R. W. Conway, Kara L. Vine, Mark Pinese, Mark J. Cowley, R F Shearer, Morghan C. Lucas, David Herrmann et al. · 2017 · Oncogene
26. Electromagnetic navigation bronchoscopy to access lung lesions in 1,000 subjects: first results of the prospective, multicenter NAVIGATE study
    for the NAVIGATE Study Investigators, Sandeep J. Khandhar, Mark Bowling, Javier Flandes, Thomas R. Gildea, Kristin L. Hood, William S Krimsky, Douglas J. Minnich, Septimiu Dan Murgu, Michael A. Pritchett et al. · 2017 · BMC Pulmonary Medicine
27. Targeting Lung Cancer Stem Cells: Research and Clinical Impacts
    Norashikin Zakaria, Nazilah Abdul Satar, Noor Hanis Abu Halim, Siti Hawa Ngalim, Narazah Mohd Yusoff, Juntang Lin, Badrul Hisham Yahaya · 2017 · Frontiers in Oncology
28. Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection
    Sen Li, Xiuwen Lan, Hongyu Gao, Zhiguo Li, Li Chen, Wenpeng Wang, Shubin Song, Yimin Wang, Chunfeng Li, Hongfeng Zhang et al. · 2017 · Journal of Cancer Research and Clinical Oncology
29. Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy
    Suneil Jain, Ciara A. Lyons, Steven M. Walker, Stephen McQuaid, Seán O. Hynes, Darren M. Mitchell, Brendan Pang, Gemma E. Logan, Andrena McCavigan, Declan M. O’Rourke et al. · 2017 · Annals of Oncology
30. Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations
    Jiaying Deng, Hu Chen, Daizhan Zhou, Junhua Zhang, Yun Chen, Qi Liu, Dashan Ai, Hanting Zhu, Li Chu, Wenjia Ren et al. · 2017 · Nature Communications
31. Special types of thyroid carcinoma
    Zubair Wahid Baloch, Virginia A. LiVolsi · 2017 · Histopathology
32. Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis
    Marc A. Attiyeh, Jayasree Chakraborty, Alexandre Doussot, Liana Langdon‐Embry, Shiana Mainarich, Mithat Gönen, Vinod P. Balachandran, Michael Ian D'Angelica, Ronald P. DeMatteo, William R. Jarnagin et al. · 2018 · Annals of Surgical Oncology
33. Construction of Bi/phthalocyanine manganese nanocomposite for trimodal imaging directed photodynamic and photothermal therapy mediated by 808 nm light
    Zhao Wang, Tao Jia, Qianqian Sun, Ye Kuang, Bin Liu, Mengshu Xu, Hui Zhu, Fei He, Shili Gai, Piaoping Yang · 2019 · Biomaterials
34. Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
    Alessandra Murabito, Emilio Hirsch, Alessandra Ghigo · 2020 · Frontiers in Cardiovascular Medicine
35. Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis
    Yilong Huang, Yunfeng Gao, Yushen Wu, Huapeng Lin · 2020 · Cancer Cell International
36. Advances in sarcoma diagnostics and treatment
    Amanda R. Dancsok, Karama Asleh, Torsten O. Nielsen · 2016 · Oncotarget
37. Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients
    Sara M. Tolaney, David R. Ziehr, Hao Guo, Mei Rosa Ng, William Thomas Barry, Michaela Jane Higgins, Steven Jay Isakoff, Jane E. Brock, Elena V. Ivanova, Cloud Peter Paweletz et al. · 2016 · The Oncologist
38. Collaborative Review of Risk Benefit Trade-offs Between Partial and Radical Nephrectomy in the Management of Anatomically Complex Renal Masses
    Simon P. Kim, Steven C. Campbell, Inderbir Singh Gill, Brian R. Lane, Hein Van Poppel, Marc C. Smaldone, Alessandro Volpe, Alexander Kutikov · 2016 · European Urology
39. AR Signaling in Breast Cancer
    Bilal G. Rahim, Ruth M. O'Regan · 2017 · Cancers
40. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker
    Xiaodong Zhao, Yanbo Liu, Shuo Yu · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
41. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer
    Malte W. Vetterlein, Björn Löppenberg, Patrick Karabon, Deepansh Dalela, Tarun Jindal, Akshay Sood, Felix K.‐H. Chun, Quoc‐Dien Trinh, Mani Menon, Firas Abdollah · 2017 · Cancer
42. Significance of the TMPRSS2:ERG gene fusion in prostate cancer
    Zhu Wang, Yuliang Wang, Jianwen Zhang, Qiyi Hu, Fan Zhi, Shengping Zhang, Dengqi Mao, Ying Zhang, Hui Liang · 2017 · Molecular Medicine Reports
43. Single Molecule Upconversion-Linked Immunosorbent Assay with Extended Dynamic Range for the Sensitive Detection of Diagnostic Biomarkers
    Zdeněk Farka, Matthias J. Mickert, Antonín Hlaváček, Petr Skládal, Hans H. Gorris · 2017 · Analytical Chemistry
44. FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Advanced or Metastatic Breast Cancer
    Anand Shah, Erik W. Bloomquist, Shenghui W. Tang, Wentao Fu, Youwei Bi, Qi Liu, Jingyu Yu, Ping Zhao, Todd R. Palmby, Kirsten B. Goldberg et al. · 2018 · Clinical Cancer Research
45. Anticancer potential of rosmarinic acid and its improved production through biotechnological interventions and functional genomics
    Mallappa Kumara Swamy, Uma Rani Sinniah, Ali Ghasemzadeh · 2018 · Applied Microbiology and Biotechnology
46. Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis
    Renxu Chang, Lele Song, Yi Xu, Yanjun Wu, Cheng Dai, Xinyu Wang, Xia Sun, Yingyong Hou, Wei Li, Xianbao Zhan et al. · 2018 · Nature Communications
47. Factors Associated With Cancer Disparities Among Low-, Medium-, and High-Income US Counties
    Jeremy M. O’Connor, Tannaz Sedghi, Meera M. Dhodapkar, Michael J. Kane, Cary Philip Gross · 2018 · JAMA Network Open
48. Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma
    Ying Wen, Xueqiong Zhou, Meiting Lu, Meiling He, Ye Tian, Lixia Liu, Mengnan Wang, Wenchong Tan, Yaotang Deng, Xushan Yang et al. · 2018 · Oncogene
49. Colorectal Cancer in African Americans: An Update
    Reneé Williams, Pascale M. White, Jose M. Nieto, Dorice L. Vieira, Fritz François, Frank A. Hamilton · 2016 · Clinical and Translational Gastroenterology
50. CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer
    Mahmoud A. Alfaqih, Erik Russell Nelson, Wen Liu, Rachid Safi, Jeffery S. Jasper, Everardo Macias, Joseph Geradts, J. Will Thompson, Laura G. Dubois, Michael R. Freeman et al. · 2017 · Cancer Research
51. Subdiaphragmatic vagotomy promotes tumor growth and reduces survival via TNFα in a murine pancreatic cancer model
    Lars Ivo Partecke, André Käding, Dung Nguyen Trung, Stephan Diedrich, Matthias Sendler, Frank Ulrich Weiß, Jens‐Peter Kühn, Julia V. Mayerle, Katharina Beyer, Wolfram von Bernstorff et al. · 2017 · Oncotarget
52. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells
    Tsz-Lun Yeung, Cecilia S. Leung, Kwong‐Kwok Wong, Arthur Gutierrez‐Hartmann, Joseph Kwong, David Marc Gershenson, Samuel C. Mok · 2017 · Oncotarget
53. Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer Cells
    Mahsa Zarei, Shruti Lal, Seth J. Parker, Avinoam Nevler, Ali Vaziri Gohar, Katerina Dukleska, Nicole Caroline Mambelli-Lisboa, Cynthia Moffat, Fernando F. Blanco, Saswati N. Chand et al. · 2017 · Cancer Research
54. The extract from Punica granatum (pomegranate) peel induces apoptosis and impairs metastasis in prostate cancer cells
    Yuanle Deng, Yali Li, Fangfang Yang, Anqi Zeng, Shuping Yang, Yi Luo, Yiwen Zhang, Yongmei Xie, Tinghong Ye, Yong Xia et al. · 2017 · Biomedicine & Pharmacotherapy
55. Curcumin Induces Autophagy, Apoptosis, and Cell Cycle Arrest in Human Pancreatic Cancer Cells
    Yaping Zhu, Shurui Bu · 2017 · Evidence-based Complementary and Alternative Medicine
56. Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review
    Netty Kinsella, Pär E. Stattin, Declan J. Cahill, Christian T. Brown, Anna Bill‐Axelson, Ola Bratt A, Sigrid Carlsson, Mieke Van Hemelrijck · 2018 · European Urology
57. Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling
    Colin H. Beckwitt, Keisuke Shiraha, Alan H. Wells · 2018 · PLoS ONE
58. A Machine Learning Approach for Identifying Gene Biomarkers Guiding the Treatment of Breast Cancer
    Ashraf Abou Tabl, Abedalrhman Alkhateeb, Waguih H. ElMaraghy, Luis G. Rueda, Alioune Ngom · 2019 · Frontiers in Genetics
59. Drug-encapsulated blend of PLGA-PEG microspheres: in vitro and in vivo study of the effects of localized/targeted drug delivery on the treatment of triple-negative breast cancer
    Jusu, S. M., Obayemi, J. D., Salifu, A. A., Nwazojie, C. C., Uzonwanne, V., Odusanya, O. S., Soboyejo, W. O. · 2020 · Scientific Reports
60. Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells
    Coombs, Melanie R. Power, Harrison, Megan E., Hoskin, David W. · 2016 · Cancer Letters
61. Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer
    Shuai Zhang, Dehai Che, Fang Yang, Chunling Chi, Hongxue Meng, Jing Shen, Qi Li, Fang Liu, Liyan Lv, Yue Li et al. · 2017 · Oncotarget
62. NEAT1 contributes to breast cancer progression through modulating miR‐448 and ZEB1
    Xing Jiang, Yong Zhou, Aijun Sun, Junli Xue · 2018 · Journal of Cellular Physiology
63. Immune landscape of papillary thyroid cancer and immunotherapeutic implications
    Kwon Joong Na, Hongyoon Choi · 2018 · Endocrine Related Cancer
64. Honey and cancer: A mechanistic review
    Marwa Waheed, Muhammad Bilal Hussain, Ahsan Javed, Zarina Mushtaq, Sadia Hassan, Mohammad Ali Shariati, Muhammad Usman Khan, Majid Rasheed Majeed, Manisha Nigam, Abhay Prakash Mishra et al. · 2018 · Clinical Nutrition
65. Thyroid Cancer Incidence Trends in the United States: Association with Changes in Professional Guideline Recommendations
    Malesa M. Pereira, Vonetta L. Williams, Julie E. Hallanger Johnson, Pablo Valderrábano · 2020 · Thyroid
66. Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways
    Bai, Xue, Fisher, David E., Flaherty, Keith T. · 2019 · Nature Reviews Clinical Oncology
67. Effects of Psychoeducational Interventions Using Mobile Apps and Mobile-Based Online Group Discussions on Anxiety and Self-Esteem in Women With Breast Cancer: Randomized Controlled Trial
    Ghanbari, Elaheh, Yektatalab, Shahrzad, Mehrabi, Manoosh · 2021 · JMIR mHealth and uHealth
68. Gastric Cancer in the Era of Precision Medicine
    Xi Liu, Stephen J. Meltzer · 2017 · Cellular and Molecular Gastroenterology and Hepatology
69. Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder
    Makito Miyake, Shunta Hori, Yosuke Morizawa, Yoshihiro Tatsumi, Michihiro Toritsuka, Sayuri Ohnishi, Keiji Shimada, Hideki Furuya, Vedbar S. Khadka, Youping Deng et al. · 2017 · Oncotarget
70. Cigarette Smoking and Pancreatic Cancer Survival
    Chen Yuan, Vicente Morales‐Oyarvide, Ana Babić, Clary B. Clish, Peter L. Kraft, Ying Bao, Zhi Rong Qian, Douglas Adam Rubinson, Kimmie Ng, Edward L. Giovannucci et al. · 2017 · Journal of Clinical Oncology
71. Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy
    Roberto Chalela, Víctor Curull, Cesar Jessé Enríquez-Rodríguez, Lara Pijuán, Beatríz Bellosillo, Joaquim Gea · 2017 · Journal of Thoracic Disease
72. Recent Trends in Ovarian Cancer Incidence and Relative Survival in the United States by Race/Ethnicity and Histologic Subtypes
    Hyo K. Park, Julie J. Ruterbusch, Michele L. Coté · 2017 · Cancer Epidemiology Biomarkers & Prevention
73. Radiotherapy and CD40 Activation Separately Augment Immunity to Checkpoint Blockade in Cancer
    Andrew J. Rech, Hannah Dada, Jonathan J. Kotzin, Jorge Henao‐Mejia, Andy J. Minn, Christina Twyman-Saint Victor, Robert H. Vonderheide · 2018 · Cancer Research
74. A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer
    Fahrmann, Johannes F, Bantis, Leonidas E, Capello, Michela, Scelo, Ghislaine, Dennison, Jennifer B, Patel, Nikul, Murage, Eunice, Vykoukal, Jody, Kundnani, Deepali L, Foretova, Lenka et al. · 2019 · JNCI: Journal of the National Cancer Institute
75. Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer
    Yingnan Yang, Rui Zhang, Jingwen Du, Heng-heng Yuan, Yanjing Li, Xiao-li Wei, Xiaoxue Du, Shulin Jiang, Yu Han · 2018 · Cancer Cell International
76. miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair–Deficient Colorectal Cancer by Targeting PD-L1
    Mai Ashizawa, Hirokazu Okayama, Teruhide Ishigame, Aung Kyi Thar Min, Katsuharu Saito, Daisuke Ujiie, Yuko Murakami, Tomohiro Kikuchi, Yuko Nakayama, Masaru Noda et al. · 2019 · Molecular Cancer Research
77. HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3
    Shanshan Dong, Ranran Wang, Hui Wang, Qi Ding, Xiao Zhou, Jing Wang, Keqiang Zhang, Ying Long, Shan Lu, Ting Hong et al. · 2019 · Journal of Experimental & Clinical Cancer Research
78. Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review
    Bin Li, Cong Yan, Jiamin Zhu, Xiaobing Chen, Qihan Fu, Hangyu Zhang, Zhou Tong, Lulu Liu, Yi Zheng, Peng Zhao et al. · 2020 · Frontiers in Immunology
79. Current concepts in tumour-derived organoids
    Ross J Porter, Graeme I. Murray, Mairi H McLean · 2020 · British Journal of Cancer
80. A perception-based nanosensor platform to detect cancer biomarkers
    Zvi A Yaari, Yoona Yang, Elana Apfelbaum, Christian Cupo, Alexander H. Settle, Quinlan Cullen, Winson Cai, Kara Long Roche, Douglas A. Levine, Martin Fleisher et al. · 2021 · Science Advances
81. Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis
    Jianxin Xue, Zhiqiang Qin, Hongzhou Cai, Chuanjie Zhang, Xiao Li, Weizhang Xu, Jingyuan Wang, Zicheng Xu, Bin Yu, Ting Xu et al. · 2017 · Oncotarget
82. Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma
    Aviram Mizrachi, Yosi Shamay, Janki Shah, Samuel Brook, Joanne Soong, Vinagolu K. Rajasekhar, John Laurence Humm, John H. Healey, Simon N. Powell, Jose M Baselga et al. · 2017 · Nature Communications
83. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery
    Marian Gutowski, Bérénice Framery, Martin C. Boonstra, Véronique Garambois, François Quénet, Karen Dumas, François Scherninski, Françoise Cailler, Alexander L. Vahrmeijer, André Pèlegrin · 2017 · Surgical Oncology
84. The next generation of immunotherapy: keeping lung cancer in check
    Ashwin Somasundaram, Timothy Francis Burns · 2017 · Journal of Hematology & Oncology
85. Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges
    Etienne Giroux Leprieur, Coraline Duménil, Catherine Julié, Violaine Giraud, Jennifer Dumoulin, Sylvie Labrune, Thierry Chinet · 2017 · European Journal of Cancer
86. Quantitative proteomics in lung cancer
    Chantal Hoi Yin Cheung, Hsueh‐Fen Juan · 2017 · Journal of Biomedical Science
87. Impact of Patient–Provider Race, Ethnicity, and Gender Concordance on Cancer Screening: Findings from Medical Expenditure Panel Survey
    Jyoti Dhar Malhotra, David Rotter, Jennifer Tsui, Adana A. M. Llanos, Bijal A. Balasubramanian, Kitaw Demissie · 2017 · Cancer Epidemiology Biomarkers & Prevention
88. Triple Signal Amplification Strategy for Ultrasensitive Determination of miRNA Based on Duplex Specific Nuclease and Bridge DNA–Gold Nanoparticles
    Bing Bo, Tian Zhang, Yiting Jiang, Haiyan Cui, Peng Miao · 2018 · Analytical Chemistry
89. Combination of Peri- and Intratumoral Radiomic Features on Baseline CT Scans Predicts Response to Chemotherapy in Lung Adenocarcinoma
    Mohammadhadi Khorrami, Monica Khunger, Alexia A. Zagouras, Pradnya Dinkar Patil, Rajat Thawani, Kaustav Bera, Prabhakar Shantha Rajiah, Pingfu Fu, Vamsidhar Velcheti, Anant Madabhushi · 2019 · Radiology Artificial Intelligence
90. Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors
    Menno Tamminga, Sanne de Wit, T. Jeroen N. Hiltermann, Wim Timens, Ed M. D. Schuuring, Leon W.M.M. Terstappen, Harry J.M. Groen · 2019 · Journal for ImmunoTherapy of Cancer
91. Electrochemical nano-genosensor for highly sensitive detection of miR-21 biomarker based on SWCNT-grafted dendritic Au nanostructure for early detection of prostate cancer
    Abbas Sabahi, Razieh Salahandish, Ali Ghaffarinejad, Eskandar Omidinia · 2019 · Talanta
92. Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma
    Fengzhi Li, Ieman A. M. Aljahdali, Renyuan Zhang, Kent L. Nastiuk, John J. Krolewski, Xiang Ling · 2021 · Journal of Experimental & Clinical Cancer Research
93. Technical challenges in the isolation and analysis of circulating tumor cells
    Emma E. van der Toom, James E. Verdone, Michael A. Gorin, Kenneth J. Pienta · 2016 · Oncotarget
94. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer
    Tamara Sequeiros, Marina Rigau, Cristina Chiva, Melania Montes, Iolanda Garcia-Grau, Marta García, Sherley Díaz, A. Celma, Irene V. Bijnsdorp, Alex Rosa Campos et al. · 2016 · Oncotarget
95. Clinical impact of 68 Ga‐prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate‐specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach
    Simone Albisinni, Carlos Artigas, Fouad Y. Aoun, Ibrahim Biaou, Julien Grosman, Thierry Gil, Eric Hawaux, Ksenija Limani, François-Xavier Otte, Alexandre Peltier et al. · 2016 · British Journal of Urology
96. Mesothelial‐to‐mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer
    Ángela Rynne‐Vidal, Chi Lam Au Yeung, José Antonio Jiménez-Heffernan, María Luisa Pérez Lozano, Lucía Cremades‐Jimeno, Carmen Bárcena, Ignacio Cristóbal García, Concepción Fernández‐Chacón, Tsz Lun Yeung, Samuel C. Mok et al. · 2017 · The Journal of Pathology
97. Cytotoxicity of thymoquinone alone or in combination with cisplatin (CDDP) against oral squamous cell carcinoma in vitro
    Omar M. Alaufi, Abdulwahab A. Noorwali, Fatheya Mohamed Zahran, Ahmed Mohamed Al-Abd, Safia Ali Al-Attas · 2017 · Scientific Reports
98. Fucoidan upregulates TLR4/CHOP-mediated caspase-3 and PARP activation to enhance cisplatin-induced cytotoxicity in human lung cancer cells
    Hsu, Hsien-Yeh, Lin, Tung-Yi, Hu, Chun-Hao, Shu, David Ta Fu, Lu, Mei-Kuang · 2018 · Cancer Letters
99. Galectin-3 activates TLR4/NF-κB signaling to promote lung adenocarcinoma cell proliferation through activating lncRNA-NEAT1 expression
    Wu Zhou, Xing Chen, Qinghua Hu, Xuliang Chen, Yingji Chen, Lingjin Huang · 2018 · BMC Cancer
100. Palladium concave nanocrystals with high-index facets accelerate ascorbate oxidation in cancer treatment
     Yu Chong, Xing Dai, Fang Ge, Renfei Wu, Lin Zhao, Xiaochuan Ma, Xin Tian, Sangyun Lee, Chao Zhang, Chunying Chen et al. · 2018 · Nature Communications